Vimarsana
Biggest News Aggregation in the World

Acute Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acute Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acute Inflammation Today - Breaking & Trending Today

Social Media Health Alert: Link With Chronic Inflammation and Mental Health - Vimarsana News

Social Media Health Alert: Link With Chronic Inflammation and Mental Health

Can your social media habits impact your health? Research reveals shocking links between screen time, inflammation, and mental well-being!

Biogen Inc.: Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS - Vimarsana News

Biogen Inc.: Biogen Data at ECTRIMS 2022 Highlight Innovation in Digital Health Focused on Advancing Treatment and Personalized Care of People Living with MS

Data demonstrate potential of Manual Dexterity Test and Konectom smartphone-based technology in measuring MS disease progressionRetrospective analysis applying machine learning, artificial intelligence

OSE Immunotherapeutics Appoints its International Scientific Advisory Board - Vimarsana News

OSE Immunotherapeutics Appoints its International Scientific Advisory Board

The Scientific Advisory Board (SAB) combines the expertise of renowned scientific and international key-opinion leaders in the fields of immunology, immuno-oncology, inflammation and immunotherapy.

Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases - Vimarsana News

Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases

Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases Corbus Pharmaceuticals Holdings, Inc. Norwood, Massachusetts, UNITED STATES Presentations about compounds in Corbus’ pipeline will highlight mechanistic studies of lenabasum, a CB2 agonist, and preclinical data from CB2 agonist oncology program and CB1 inverse agonist metabolism program Norwood, MA, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Compa...